Literature DB >> 28972154

Neutrophil microparticle production and inflammasome activation by hyperglycemia due to cytoskeletal instability.

Stephen R Thom1, Veena M Bhopale2, Kevin Yu2, Weiliang Huang3, Maureen A Kane3, David J Margolis4.   

Abstract

Microparticles are lipid bilayer-enclosed vesicles produced by cells under oxidative stress. MP production is elevated in patients with diabetes, but the underlying cellular mechanisms are poorly understood. We hypothesized that raising glucose above the physiological level of 5.5 mm would stimulate leukocytes to produce MPs and activate the nucleotide-binding domain, leucine-rich repeat pyrin domain-containing 3 (NLRP3) inflammasome. We found that when incubated in buffer with up to 20 mm glucose, human and murine neutrophils, but not monocytes, generate progressively more MPs with high interleukin (IL)-1β content. Enhanced MP production required generation of reactive chemical species by mitochondria, NADPH oxidase, and type 2 nitric-oxide synthase (NOS-2) and resulted in S-nitrosylation of actin. Depleting cells of capon (C-terminal PDZ ligand of neuronal nitric-oxide synthase protein), apoptosis-associated speck-like protein containing C-terminal caspase recruitment domain (ASC), or pro-IL-1β prevented the hyperglycemia-induced enhancement of reactive species production, MP generation, and IL-1β synthesis. Additional components required for these responses included inositol 1,3,5-triphosphate receptors, PKC, and enhancement of filamentous-actin turnover. Numerous proteins become localized to short filamentous actin in response to S-nitrosylation, including vasodilator-stimulated phosphoprotein, focal adhesion kinase, the membrane phospholipid translocation enzymes flippase and floppase, capon, NLRP3, and ASC. We conclude that an interdependent oxidative stress response to hyperglycemia perturbs neutrophil cytoskeletal stability leading to MP production and IL-1β synthesis.
© 2017 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  NLRP3; actin; inflammasome; interleukin 1 (IL-1); nitric oxide; nitrosylation

Mesh:

Substances:

Year:  2017        PMID: 28972154      PMCID: PMC5672053          DOI: 10.1074/jbc.M117.802629

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  84 in total

1.  Monocytic microparticles activate endothelial cells in an IL-1β-dependent manner.

Authors:  Jian-Guo Wang; Julie C Williams; Beckley K Davis; Ken Jacobson; Claire M Doerschuk; Jenny P-Y Ting; Nigel Mackman
Journal:  Blood       Date:  2011-06-23       Impact factor: 22.113

2.  Elevated numbers of tissue-factor exposing microparticles correlate with components of the metabolic syndrome in uncomplicated type 2 diabetes mellitus.

Authors:  Michaela Diamant; Rienk Nieuwland; Renée F Pablo; Augueste Sturk; Jan W A Smit; Jasper K Radder
Journal:  Circulation       Date:  2002-11-05       Impact factor: 29.690

3.  Monocytes Take Their Own Path to IL-1β.

Authors:  Eric I Elliott; Fayyaz S Sutterwala
Journal:  Immunity       Date:  2016-04-19       Impact factor: 31.745

Review 4.  Hydroethidine- and MitoSOX-derived red fluorescence is not a reliable indicator of intracellular superoxide formation: another inconvenient truth.

Authors:  Jacek Zielonka; B Kalyanaraman
Journal:  Free Radic Biol Med       Date:  2010-01-29       Impact factor: 7.376

5.  Gene expression, synthesis, and secretion of interleukin 18 and interleukin 1beta are differentially regulated in human blood mononuclear cells and mouse spleen cells.

Authors:  A J Puren; G Fantuzzi; C A Dinarello
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-02       Impact factor: 11.205

6.  Elevated levels of VE-cadherin-positive endothelial microparticles in patients with type 2 diabetes mellitus and coronary artery disease.

Authors:  Hidenobu Koga; Seigo Sugiyama; Kiyotaka Kugiyama; Keisuke Watanabe; Hironobu Fukushima; Tomoko Tanaka; Tomohiro Sakamoto; Michihiro Yoshimura; Hideaki Jinnouchi; Hisao Ogawa
Journal:  J Am Coll Cardiol       Date:  2005-05-17       Impact factor: 24.094

7.  Common variation in the NOS1AP gene is associated with reduced glucose-lowering effect and with increased mortality in users of sulfonylurea.

Authors:  Matthijs L Becker; Albert-Jan L H J Aarnoudse; Christopher Newton-Cheh; Albert Hofman; Jacqueline C M Witteman; André G Uitterlinden; Loes E Visser; Bruno H Ch Stricker
Journal:  Pharmacogenet Genomics       Date:  2008-07       Impact factor: 2.089

8.  Increased carbon dioxide levels stimulate neutrophils to produce microparticles and activate the nucleotide-binding domain-like receptor 3 inflammasome.

Authors:  Stephen R Thom; Veena M Bhopale; JingPing Hu; Ming Yang
Journal:  Free Radic Biol Med       Date:  2017-03-10       Impact factor: 7.376

9.  Mind the gap: disparity between research funding and costs of care for diabetic foot ulcers.

Authors:  David G Armstrong; Vikram A Kanda; Lawrence A Lavery; William Marston; Joseph L Mills; Andrew J M Boulton
Journal:  Diabetes Care       Date:  2013-07       Impact factor: 19.112

Review 10.  Mechanisms of NOS1AP action on NMDA receptor-nNOS signaling.

Authors:  Michael J Courtney; Li-Li Li; Yvonne Y Lai
Journal:  Front Cell Neurosci       Date:  2014-08-27       Impact factor: 5.505

View more
  20 in total

Review 1.  Cells under stress: The mechanical environment shapes inflammasome responses to danger signals.

Authors:  Hemant Joshi; Sharon Celeste Morley
Journal:  J Leukoc Biol       Date:  2019-01-15       Impact factor: 4.962

Review 2.  The role of neutrophils in thrombosis.

Authors:  Sargam Kapoor; Aman Opneja; Lalitha Nayak
Journal:  Thromb Res       Date:  2018-08-09       Impact factor: 3.944

3.  Neutrophils as a Potential Source of Chitinase-3-like Protein 1 in Cystic Fibrosis.

Authors:  Adèle Coriati; Chantal Massé; Aurélie Ménard; Guillaume F Bouvet; Yves Berthiaume
Journal:  Inflammation       Date:  2018-10       Impact factor: 4.092

Review 4.  Blood Cell-Derived Microvesicles in Hematological Diseases and beyond.

Authors:  Hara T Georgatzakou; Sotirios P Fortis; Effie G Papageorgiou; Marianna H Antonelou; Anastasios G Kriebardis
Journal:  Biomolecules       Date:  2022-06-08

Review 5.  Challenges and directions in studying cell-cell communication by extracellular vesicles.

Authors:  Guillaume van Niel; David R F Carter; Aled Clayton; Daniel W Lambert; Graça Raposo; Pieter Vader
Journal:  Nat Rev Mol Cell Biol       Date:  2022-03-08       Impact factor: 113.915

Review 6.  Skin cell-derived extracellular vesicles: a promising therapeutic strategy for cutaneous injury.

Authors:  Min Wang; Peipei Wu; Jin Huang; Wenhui Liu; Hui Qian; Yaoxiang Sun; Hui Shi
Journal:  Burns Trauma       Date:  2022-10-18

7.  Plasma gelsolin modulates the production and fate of IL-1β-containing microparticles following high-pressure exposure and decompression.

Authors:  Veena M Bhopale; Deepa Ruhela; Kaighley D Brett; Nathan Z Nugent; Noelle K Fraser; Susan L Levinson; Mark J DiNubile; Stephen R Thom
Journal:  J Appl Physiol (1985)       Date:  2021-03-25

Review 8.  COVID-19 Infection and Circulating Microparticles-Reviewing Evidence as Microthrombogenic Risk Factor for Cerebral Small Vessel Disease.

Authors:  Che Mohd Nasril Che Mohd Nassir; Sabarisah Hashim; Kah Keng Wong; Sanihah Abdul Halim; Nur Suhaila Idris; Nanthini Jayabalan; Dazhi Guo; Muzaimi Mustapha
Journal:  Mol Neurobiol       Date:  2021-06-26       Impact factor: 5.590

Review 9.  Fibrosis of the diabetic heart: Clinical significance, molecular mechanisms, and therapeutic opportunities.

Authors:  Izabela Tuleta; Nikolaos G Frangogiannis
Journal:  Adv Drug Deliv Rev       Date:  2021-07-29       Impact factor: 17.873

Review 10.  The Effects of Type 2 Diabetes Mellitus on Organ Metabolism and the Immune System.

Authors:  Gholamreza Daryabor; Mohamad Reza Atashzar; Dieter Kabelitz; Seppo Meri; Kurosh Kalantar
Journal:  Front Immunol       Date:  2020-07-22       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.